Abstract:Dendritic cells (DC), as potent antigen-presenting cells (APC), constitute a complex system of cells that initiate and regulate immune responses that result in two opposite outcomes: immunity or tolerance. The fine regulation of these two distinct functions is not completely understood. After loading with antigen, DC exhibit the properties of both antigen and adjuvant, the functional components of vaccines. For a long time, attention has focused on the exceptional ability of DC as professional APC capable of eliciting T and B cell-mediated responses, and on their potential as immunotherapy in cancer. DC exhibit both heterogeneity and plasticity. On the one hand, distinct DC subsets exhibit distinct functions. On the other hand, DC functions can be altered by the cytokine environment or other factors. There is increasing evidence that DC could be used as a tool to induce peripheral tolerance. Because DC-based immunotherapy in autoimmune diseases depends on tolerogenic DC, discerning markers for tolerogenic DC is of great importance. Immature DC, plasmacytoid DC and interleukin-10-modified DC can mediate immune tolerance by inducing T-cell anergy or T-helper type 2 responses. Several possibilities exist for rational modulation of DC to achieve therapeutic tolerance against autoimmune diseases. The final goal is to create optimal prerequisites to use autologous DC that are prepared from the individual patient with autoimmune disease, to render such DC tolerogenic by exposure in vitro to factors that promote tolerogenicity, and to re-infuse these pretreated DC to the patient in order to treat the ongoing autoimmune disease and prevent its future exacerbation.

Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance

Progress on Dendritic Cell Vaccines in Tumor Immunotherapy

Dendritic Cell Vaccine Design: Strategies for Eliciting Peripheral Tolerance as Therapy of Autoimmune Diseases

Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases

Strategies for Generating Regulatory Dendritic Cells and the Clinical Application of Immune Tolerance

Prevention of Allograft Rejection by in Vitro Generated Tolerogenic Dendritic Cells

Tolerogenic dendritic cells: the ins and outs of outcome.

212 Co-delivery of Vitamin D3 and Antigens by Nanoparticles Enhances Immune Tolerance Through Induction of Tolerogenic Dendritic Cells in Vivo

Cationic nanoparticles-based approaches for immune tolerance induction in vivo

Emerging Strategies for Treating Autoimmune Disease with Genetically Modified Dendritic Cells

[The Recent Advances in the Study of Dendritic Cells and Induction of Donor Antigen-Specific T Cell Tolerance].

Tolerogenic dendritic cells in organ transplantation

Targeting Lymphoid Tissues to Promote Immune Tolerance

Tolerogenic Dendritic Cells Transferring Hyporesponsiveness and Synergizing T Regulatory Cells in Transplant Tolerance

Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble Tnf Receptor

Nanomaterials for antigen-specific immune tolerance therapy

Recent Advances in the Development of Nanomaterials for Dc-Based Immunotherapy

Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy.

The role of dendritic cells in cancer immunity and therapeutic strategies

Generating tolerogenic dendritic cells with neuropeptides

Research progress on immunomodulatory effect of plant components on dendritic cells